Last reviewed · How we verify

IPV IM Device

London School of Hygiene and Tropical Medicine · FDA-approved active Small molecule

IPV IM Device is an intradermal delivery device designed to administer inactivated polio vaccine (IPV) via the intramuscular route with improved immunogenicity and reduced antigen requirements.

IPV IM Device is an intradermal delivery device designed to administer inactivated polio vaccine (IPV) via the intramuscular route with improved immunogenicity and reduced antigen requirements. Used for Poliomyelitis prevention via intradermal or intramuscular IPV administration.

At a glance

Generic nameIPV IM Device
Also known asIntramuscular Inactivated Poliovirus Vaccine using intramuscular Jet injector device
SponsorLondon School of Hygiene and Tropical Medicine
Drug classvaccine delivery device
ModalitySmall molecule
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

The device enables intradermal or intramuscular administration of IPV using a smaller vaccine dose compared to standard intramuscular injection, potentially enhancing immune response while reducing antigen load. This approach aims to improve vaccination efficiency and reduce vaccine wastage, particularly relevant for resource-limited settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: